Immunophenotypic characterization of normal blood CD56+loversus CD56+hiNK-cell subsets and its impact on the understanding of their tissue distribution and functional properties

Blood Cells, Molecules, and Diseases

Volumn 27, Issue 4, 2001, Pages 731-743

  Lima, Margarida ^a   Dos Anjos Teixeira, Maria ^a   Queirós, Maria Luís ^a   Leite, Marina ^a   Santos, Ana Helena ^a   Justiça, Benvindo ^a   Orfão, Alberto ^b  

^a HOSPITAL DE SANTO ANTÓNIO   (Portugal)

^b Centro de Investigacion del Cancer   (Spain)

Author keywords

Blood; CD56; Flow cytometry; Immunophenotype; NK cells

Indexed keywords

CD11 ANTIGEN; CD16 ANTIGEN; CD2 ANTIGEN; CD45 ANTIGEN; CD56 ANTIGEN; CD7 ANTIGEN; CD94 ANTIGEN; CELL ADHESION MOLECULE; HERMES ANTIGEN; HLA DR ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ARTICLE; CELL MIGRATION; CONJUGATION; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; LIGHT SCATTERING; LYMPHOCYTE SUBPOPULATION; NATURAL KILLER CELL; NORMAL HUMAN; PRIORITY JOURNAL; TARGET CELL; TISSUE DISTRIBUTION;

EID: 0034748087     PISSN: 10799796     EISSN: None     Source Type: Journal    
DOI: 10.1006/bcmd.2001.0443     Document Type: Article

References (94)

1. The origin and functions of natural killer cells
2. The relationship of CD16 (Leu 11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes
3. Human uterine natural killer cells
4. Phenotypic comparison of natural killer cells from peripheral blood and from early pregnancy deciduas
5. A distinct distribution of natural killer cell subgroups in human tissues and blood
6. Comparative studies of human FcRIII-positive and negative natural killer cells
7. Human natural killer cells: A unique innate immunoregulatory role for the CD56 (bright) subset
8. Differential phenotypic properties of human peripheral blood CD56dim+ and CD56bright+ natural killer cell subpopulations
9. Regulation of adhesion and transendothelial migration of natural killer cells
10. Migratory functions of natural killer cells
11. Costimulation of human natural killer cell proliferation: Role of accessory cytokines and cell contact-dependent signals
12. Human NK cells: Their ligands, receptors and functions
13. Natural killer cell-target cell interactions
14. Natural killer cells: Endothelial interactions, migration, and target cell recognition
15. Adhesion in NK cell function
16. Lymphocyte homing and homeostasis
17. Mechanisms that regulate the function of the selectins and their ligands
18. Function of lymphocyte homing-associated adhesion molecules on human natural killer and lymphokine-activated killer cells
19. CD44 cell adhesion molecules
20. Differential expression and function of L-selectin on CD56bright and CD56dim natural killer cell subsets
21. Leukocyte CD11/CD18 integrins: Biological and clinical relevance
22. A human leukocyte differentiation antigen family with distinct alpha-subunits and a common beta-subunit: The lymphocyte function-associated antigen (LFA-1), the C3bi complement receptor (OKM1/Mac-1), and the p150, 95 molecule
23. Molecules and structures involved in the adhesion of natural killer cells to vascular endothelium
24. Expression of integrins and other adhesion molecules on NK cells: Impact of IL-2 on short- and long-term cultures
25. A subpopulation of Mac-1 (CD11b/CD18) molecules mediates neutrophil adhesion to ICAM-1 and fibrinogen
26. Characterization of the function of intercellular adhesion molecule (ICAM)-3 and comparison with ICAM-1 and ICAM-2 in immune responses
27. Intercellular adhesion molecule-2 (CD102) binds to the leukocyte integrin CD11b/CD18 through the A domain
28. Activation of natural killer cell migration by leukocyte integrin-binding peptide from intracellular adhesion molecule-2 (ICAM-2)
29. The structure of the two amino-terminal domains of human ICAM-1 suggests how it functions as a rhinovirus receptor and as an LFA-1 integrin ligand
30. Differential requirements for LFA-1 binding to ICAM-1 and LFA-1-mediated cell aggregation
31. Contribution of CR3, CD11b/CD18 to cytolysis by human NK cells
32. CR3 (CD11b, CD18): A phagocyte and NK cell membrane receptor with multiple ligand specificities and functions
33. Isolation of complement-fragment-iC3b-binding proteins by affinity chromatography. The identification of p150, 95 as an iC3b-binding protein
34. Characteristics of fibrinogen binding to the domain of CD11c, an alpha subunit of p150, 95
35. A monoclonal antibody, 3/22, to rabbit CD11c which induces homotypic T cell aggregation: Evidence that ICAM-1 is a ligand for CD11c/CD18
36. Leukocyte integrin P150, 95 (CD11c/CD18) functions as an adhesion molecule binding to a counter-receptor on stimulated endothelium
37. Membrane glycoprotein p150, 95 of human cytotoxic T cell clones is involved in conjugate formation with target cells
38. CD57+ T lymphocytes are derived from CD57- precursors by differentiation occurring in late immune responses
39. Molecular and functional analysis of human natural killer cell-associated neural cell adhesion molecule (N-CAM/CD56)
40. CD56 directly interacts in the process of NCAM-positive target-cell killing by NK cells
41. The function of LFA-1 in cell-mediated killing and adhesion: Studies on heritable LFA-1, Mac-1 deficiency and on lymphoid cell self-aggregation
42. Functional characterization of LFA-1 antigens in the interaction of human NK clones and target cells
43. LFA-1, LFA-2, and LFA-3 antigens are involved in CTL-target conjugation
44. The structure and ligand interactions of CD2: Implications for T-cell function
45. Cell-cell adhesion mediated by CD8 and MHC class I molecules
46. Interaction between CD8 and major histocompatibility complex (MHC) class I mediated by multiple contact surfaces that include the alpha 2 and alpha 3 domains of MHC class I
47. Surface receptors delivering opposite signals regulate the function of human NK cells
48. NK cell activation: Distinct stimulatory pathways counterbalancing inhibitory signals
49. Signaling pathways engaged by NK cell receptors: Double concerto for activating receptors, inhibitory receptors and NK cells
50. Immunoreceptor tyrosine based inhibition motifs
51. Signal transduction by human NK-cell MHC-recognizing receptors
52. Signal transduction during NK-cell activation: Balancing opposing forces
53. Early signaling via inhibitory and activating NK receptors
54. Functional and biochemical analysis of CD16 antigen on natural killer cells and granulocytes
55. Interaction of Fc receptor (CD16) ligands induces transcription of interleukin 2 receptor (CD25) and lymphokine genes and expression of their products on human natural killer cells
56. Structure and function of the CD16:zeta: Gamma complex expressed on human natural-killer cells
57. Receptors for the Fc fragment of IgG on natural killer cells
58. Human CD16 as a lysis receptor mediating direct natural killer cell cytotoxicity
59. Quantitative analysis of the effect of CD16 ligation on human NK cell proliferation
60. A subset of CD16-natural killer cells without antibody-dependent cellular cytotoxicity function
61. Phenotypic and functional cellular differences between human CD3- decidual and peripheral blood leukocytes
62. Divergent functions of lectin-like receptors on NK cells
63. Major histocompatibility complex class I-specific receptors on human natural killer and T lymphocytes
64. Specificity and function of immunoglobulin superfamily NK cell inhibitory and stimulatory receptors
65. NK cell receptors
66. The human natural cytotoxicity receptors (NCR) that induce HLA class I-independent NK cell triggering
67. HLA-E is the ligand for the natural killer cell CD94/NKG2 receptors
68. Regulation of NK cell functions through interaction of the CD94/NKG2 receptors with the nonclassicalclass I molecule HLA-E
69. NK cell recognition of non-classical HLA class I molecules
70. T11/CD2 activation of cloned human natural killer cells results in increased conjugate formation and exocytosis of cytolytic granules
71. CD2 is functionally linked to the zeta-natural killer receptor complex
72. Activation-induced NK cell death triggered by CD2 stimulation
73. Expression and function of CD7 molecule on human natural killer cells
74. Structure and function of the CD7 molecule
75. Role of CD38 and its ligand in the regulation of MHC-nonrestricted cytotoxic T cells
76. CD38 triggers cytotoxic responses in activated human natural killer cells
77. Interaction of natural killer cells with extracellular matrix induces early intracellular signalling events and enhances cytotoxic functions
78. Signaling pathways regulating CD44-dependent cytolysis in natural killer cells
79. Absence of B7.1-CD28/CTLA-4-mediated co-stimulation in human NK cells
80. A new mechanism of NK cell cytotoxicity activation: The CD40-CD40 ligand interaction
81. Differential effects of IL12 and IL2 on expression and function of cellular adhesion molecules on purified human natural killer cells
82. Interleukin 2 receptor gamma chain expression on resting and activated lymphoid cells
83. Loss of activation-induced CD45RO with maintenance of CD45RA expression during prolonged culture of T cells and NK cells
84. Expression of a functional c-kit receptor on a subset of natural killer cells
85. Interleukin (IL)-15 is a novel cytokine that activates human natural killer cells via components of the IL2 receptor
86. Immunoregulatory effects of cytokines on natural killer cells
87. Analysis of the costimulatory role of IL-2 and IL- 15 in initiating proliferation of resting (CD56dim) human NK cells
88. IL-10 enhances NK cell proliferation, cytotoxicity and production of IFN-gamma when combined with IL-18
89. Synergistic proliferation and activation of natural killer cells by interleukin 12 and interleukin 18
90. Interleukin 2 receptors
91. Constitutive expression of high affinity interleukin 2 receptors on human CD16-natural killer cells in vivo
92. Functional consequences of interleukin 2 receptor expression on resting human lymphocytes. Identification of a novel natural killer cell subset with high affinity receptors
93. Differential responses to interleukin 2 define functionally distinct subsets of human natural killer cells
94. CD56bright natural killer cell subsets: Characterization of distinct functional responses to interleukin-2 and the c-kit ligand